JB Pharma publishes its maiden sustainability report
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The company increases its efficiency and is able to face the growing demand for its services.
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Both products are broad-spectrum, foliar insecticides used across wide range of crops
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Subscribe To Our Newsletter & Stay Updated